Castration-Resistant Prostate Cancer
Castration-resistant prostate cancer (CRPC) is a type of prostate cancer that continues to grow despite hormone therapy aimed at lowering testosterone levels.
We are exploring how PARP-PET imaging can help in diagnosing and monitoring solid tumors. This study aims to see if it provides better insights compared to standard imaging methods.
Health conditions and diseases that the clinical trial is designed to study and treat.
Castration-resistant prostate cancer (CRPC) is a type of prostate cancer that continues to grow despite hormone therapy aimed at lowering testosterone levels.
Metastatic breast cancer occurs when breast cancer cells spread to other parts of the body, such as bones, liver, or lungs, leading to various symptoms.
Metastatic ovarian cancer is when cancer that started in the ovaries spreads to other areas of the body, often leading to serious health issues.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.